...
首页> 外文期刊>Journal of Clinical Microbiology >Invasive Meningococcal Disease in Québec, Canada, Due to an Emerging Clone of ST-269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1.19 (B:17:P1.19)
【24h】

Invasive Meningococcal Disease in Québec, Canada, Due to an Emerging Clone of ST-269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1.19 (B:17:P1.19)

机译:加拿大魁北克的侵袭性脑膜炎球菌病,是由于ST-269血清型B型脑膜炎球菌的克隆与血清型抗原17和血清亚型抗原P1.19(B:17:P1.19)

获取原文
           

摘要

During periods of endemic meningococcal disease, serogroup B Neisseria meningitidis is responsible for a significant percentage of invasive diseases, and no particular clone or strain predominates (F. E. Ashton and D. A. Caugant, Can. J. Microbiol. 47: 293-289, 2001), However, in the winter of 2004 to 2005, a cluster of serogroup B meningococcal disease occurred in one region in the province of Québec, Canada. The N. meningitidis strain responsible for this cluster of cases was identified as sequence type ST-269 with the antigenic formula B:17:P1.19. Retrospective analysis of isolates from 2000 onwards showed that this clone first emerged in the province of Québec in 2003. The emergence of this clone of serogroup B meningococci occurred after a mass vaccination against serogroup C N. meningitidis, suggesting possible capsule replacement.
机译:在地方性脑膜炎球菌疾病期间,血清B型脑膜炎奈瑟菌(Neisseria meningitidis)导致了很大比例的侵袭性疾病,并且没有特定的克隆或毒株占主导地位(FE Ashton和DA Caugant,Can。J. Microbiol。47: 293-289,2001年),但是,在2004年至2005年冬天,加拿大魁北克省的一个地区发生了B群脑膜炎球菌群。 N。负责该类病例的脑膜炎菌株被鉴定为具有抗原式B:17:P1.19的序列类型ST-269。从2000年开始的分离株回顾性分析表明,该克隆于2003年在魁北克省首次出现。该B群脑膜炎球菌的克隆出现于针对C N血清群的大规模疫苗接种之后。脑膜炎,提示可能要更换胶囊。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号